5-amino-2,4-dihydroxy-alpha-methylphenylethylamine has been researched along with sincalide in 1 studies
Studies (5-amino-2,4-dihydroxy-alpha-methylphenylethylamine) | Trials (5-amino-2,4-dihydroxy-alpha-methylphenylethylamine) | Recent Studies (post-2010) (5-amino-2,4-dihydroxy-alpha-methylphenylethylamine) | Studies (sincalide) | Trials (sincalide) | Recent Studies (post-2010) (sincalide) |
---|---|---|---|---|---|
10 | 0 | 0 | 4,015 | 72 | 533 |
Protein | Taxonomy | 5-amino-2,4-dihydroxy-alpha-methylphenylethylamine (IC50) | sincalide (IC50) |
---|---|---|---|
Cholecystokinin receptor type A | Rattus norvegicus (Norway rat) | 0.0006 | |
Cholecystokinin receptor type A | Homo sapiens (human) | 0.0006 | |
Gastrin/cholecystokinin type B receptor | Homo sapiens (human) | 0.001 | |
Gastrin/cholecystokinin type B receptor | Mus musculus (house mouse) | 0.0008 | |
Cholecystokinin receptor type A | Cavia porcellus (domestic guinea pig) | 0.0004 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Antonijevic, I; Leng, G; Luckman, SM; Onaka, T; Palmer, JR | 1 |
1 other study(ies) available for 5-amino-2,4-dihydroxy-alpha-methylphenylethylamine and sincalide
Article | Year |
---|---|
Involvement of the noradrenergic afferents from the nucleus tractus solitarii to the supraoptic nucleus in oxytocin release after peripheral cholecystokinin octapeptide in the rat.
Topics: Afferent Pathways; Animals; Immunohistochemistry; Injections, Intraventricular; Male; Microspheres; Neurons; Neurotoxins; Norepinephrine; Oxytocin; Phenethylamines; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; Rhodamines; Sincalide; Solitary Nucleus; Supraoptic Nucleus | 1995 |